CALCA and medullary thyroid gland carcinoma: Surprisingly, it was only after this second surgery that it became known that the patient had been under follow-up and treatment (with somatostatin analogues—SSAs and periodic monitoring of serum calcitonin and CEA levels) for multi-metastatic medullary thyroid carcinoma since 1994.